CureVac

change direction new plan alter arrows move reprioritize

CureVac gains $430M GSK vaccine contract, loses 30% of staff

CureVac shared news of the deal alongside a restructuring that will put 30% of its employees out of work and extend its cash runway into 2028.

Nick Paul Taylor Jul 3, 2024 5:00am

parachute mountains sunset clouds

Xaira, Anthos, CureVac & more—Chutes & Ladders

Apr 26, 2024 8:30am

Road block challenges clinical hold problems

CureVac, chasing Moderna mRNA flu shot, hits similar problems

Apr 4, 2024 9:30am

mRNA vaccine

CureVac touts COVID-19 vax data despite adverse events

Jan 5, 2024 11:16am

Hand picking a red apple off a tree in an orchard

CureVac hand-picks mRNA flu vaccine but keeps data tucked away

Sep 12, 2023 10:45am

unlabeled vaccine

LimmaTech regains shigella shot from GSK, new CEO from CureVac

Jul 20, 2023 10:31am